Bizwit Research & Consulting LLP is a global provider of business intelligence & consulting services. We have a strong primary base of key industry leaders along with the chain of industry analysts to analyze the market trends and its future impact in order to estimates and forecast different business segments and markets. 

Global Plasma Fractionation Market to reach USD 58.42 billion by the end of 2030.

Global Plasma Fractionation Market Size study & Forecast, by Product ( Albumin, Immunoglobulins, Coagulation Factors, Protease Inhibitors, Others), by Method (Centrifugation, Depth Filtration, Chromatography, Others)by Application (Neurology, Hematology, Oncology, Immunology, Pulmonology, Others), by End User(Hospitals & Clinics, Clinical Research, Others) and Regional Analysis, 2023-2030

Product Code: HLSB-89737339
Publish Date: 27-06-2023
Page: 200

Global Plasma Fractionation Market is valued approximately USD 30.87 billion in 2022 and is anticipated to grow with a healthy growth rate of more than 8.3% over the forecast period 2023-2030. Plasma fractionation is a process used to separate different components of blood plasma, such as proteins and other bioactive substances. Blood plasma is the liquid component of blood that remains after red blood cells, white blood cells, and platelets have been removed. Plasma fractionation plays a vital role in the production of various therapeutic products, including immunoglobulins, albumin, clotting factors, and other specialized plasma-derived products. These products are used for treating a wide range of medical conditions, such as immune deficiencies, hemophilia, clotting disorders, and certain neurological diseases. The Plasma Fractionation market is expanding because of factors such as growing incidences of immunodeficiency disorders, surge in demand for plasma derived medicinal products and growing geriatric population.

Worldwide, there has been a significant increase in demand for plasma-derived medicines. Strong growth in immunoglobulin demand resulted in positive market expansion on a global scale. The increase in incidence of various immunodeficiency illnesses around the world is the cause of the rising demand. Immunoglobulin substitution therapy or specialized immunoglobulin therapies can be used to treat such illnesses. As a result, the market is driven by the rising demand for these therapies and the consequent growth in immunoglobulin synthesis by these techniques according to UNAIDS, 37.7 million people globally faced Human Immunodeficiency Virus (HIV) in 2020. Along with these, according to The Centres for Disease Control and Prevention (CDC) in the United States in 2021, there were between 3,000 and 6,000 people have the Guillain-Barré Syndrome. The U.S. Food and Drug Administration (FDA) has approved IVIG for use in children with HIV in order to reduce the risk of bacterial infections. The demand for plasma-derived therapies increased as a result of the increasing frequency of various immunodeficiency disorders and other diseases, which aided in the expansion of the global market. In addition, adoption of Plasma Proteins in immunology & neurology procedures and increasing R&D projects involving plasma treatments. The successful launch of this product may provide patients with an alternative option is creating lucrative growth to the market. However, the high cost of plasma fractionation and emergence of recombinant therapies as an alternative to plasma derived medicines stifles market growth throughout the forecast period of 2023-2030.

The key regions considered for the Global Plasma Fractionation Market study includes Asia Pacific, North America, Europe, Latin America, and Middle East & Africa. North America dominated the market in 2022 owing to the dominance of branded products and the region’s increasing disease prevalence. Asia Pacific is expected to grow significantly during the forecast period, owing to factors such as rising geriatric and target populations, an increase in the number of collaborations for product development, geographic expansion of key players, and active participation of government and nonprofit organizations in the market space.

Major market player included in this report are:
Grifols S.A.
CSL Limited
Takeda Pharmaceutical Company Limited
Octapharma AG
Kedrion S.p.A
Biotest AG
Bio Products Laboratory Ltd.
Intas Pharmaceuticals Ltd

Recent Developments in the Market:
Ø In January 2022, Octapharma AG released information regarding the subcutaneous human immunoglobulin cutaquig, its indication has recently been expanded by the European Union (EU). The expansion would provide patients with acquired immune deficiencies with more diverse treatment options.
Ø In June 2021, LFB Plasma has acquired ImmunoTek Bio Centre. A reliable and continuous supply of plasma will be available in the United States due to the acquisition of the plasma collection facility.

Global Plasma Fractionation Market Report Scope:
ü Historical Data – 2020 – 2021
ü Base Year for Estimation – 2022
ü Forecast period – 2023-2030
ü Report Coverage – Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
ü Segments Covered – Product, Method, Application, End User, Region
ü Regional Scope – North America; Europe; Asia Pacific; Latin America; Middle East & Africa
ü Customization Scope – Free report customization (equivalent up to 8 analyst’s working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Product:
Coagulation Factors
Protease Inhibitors

By Method:
Depth Filtration

By Application:

By End User:
Hospitals & Clinics
Clinical Research

By Region:

North America


Asia Pacific
South Korea

Latin America

Middle East & Africa
Saudi Arabia
South Africa
Rest of Middle East & Africa

Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2020-2030 (USD Billion)
1.2.1. Plasma Fractionation Market, by Region, 2020-2030 (USD Billion)
1.2.2. Plasma Fractionation Market, by Product, 2020-2030 (USD Billion)
1.2.3. Plasma Fractionation Market, by Method, 2020-2030 (USD Billion)
1.2.4. Plasma Fractionation Market, by Application, 2020-2030 (USD Billion)
1.2.5. Plasma Fractionation Market, by End User, 2020-2030 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Plasma Fractionation Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Industry Evolution
2.2.2. Scope of the Study
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Plasma Fractionation Market Dynamics
3.1. Plasma Fractionation Market Impact Analysis (2020-2030)
3.1.1. Market Drivers Growing Incidences of Immunodeficiency Disorders Surge in Demand for Plasma Derived Medicinal Products Growing Geriatric Population
3.1.2. Market Challenges Emergence of Recombinant Therapies as an Alternative to Plasma Derived Medicines
3.1.3. Market Opportunities Adoption of Plasma Proteins in Immunology & Neurology Procedures Increasing R&D projects involving plasma treatments
Chapter 4. Global Plasma Fractionation Market Industry Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.2. Porter’s 5 Force Impact Analysis
4.3. PEST Analysis
4.3.1. Political
4.3.2. Economical
4.3.3. Social
4.3.4. Technological
4.3.5. Environmental
4.3.6. Legal
4.4. Top investment opportunity
4.5. Top winning strategies
4.6. COVID-19 Impact Analysis
4.7. Disruptive Trends
4.8. Industry Expert Perspective
4.9. Analyst Recommendation & Conclusion
Chapter 5. Global Plasma Fractionation Market, by Product
5.1. Market Snapshot
5.2. Global Plasma Fractionation Market by Product, Performance – Potential Analysis
5.3. Global Plasma Fractionation Market Estimates & Forecasts by Product 2020-2030 (USD Billion)
5.4. Plasma Fractionation Market, Sub Segment Analysis
5.4.1. Albumin
5.4.2. Immunoglobulins
5.4.3. Coagulation Factors
5.4.4. Protease Inhibitors
5.4.5. Others
Chapter 6. Global Plasma Fractionation Market, by Method
6.1. Market Snapshot
6.2. Global Plasma Fractionation Market by Method, Performance – Potential Analysis
6.3. Global Plasma Fractionation Market Estimates & Forecasts by Method 2020-2030 (USD Billion)
6.4. Plasma Fractionation Market, Sub Segment Analysis
6.4.1. Centrifugation
6.4.2. Depth Filtration
6.4.3. Chromatography
6.4.4. Others
Chapter 7. Global Plasma Fractionation Market, by Application
7.1. Market Snapshot
7.2. Global Plasma Fractionation Market by Application, Performance – Potential Analysis
7.3. Global Plasma Fractionation Market Estimates & Forecasts by Application 2020-2030 (USD Billion)
7.4. Plasma Fractionation Market, Sub Segment Analysis
7.4.1. Neurology
7.4.2. Hematology
7.4.3. Oncology
7.4.4. Immunology
7.4.5. Pulmonology
7.4.6. Others
Chapter 8. Global Plasma Fractionation Market, by End User
8.1. Market Snapshot
8.2. Global Plasma Fractionation Market by End User, Performance – Potential Analysis
8.3. Global Plasma Fractionation Market Estimates & Forecasts by End User 2020-2030 (USD Billion)
8.4. Plasma Fractionation Market, Sub Segment Analysis
8.4.1. Hospitals & Clinics
8.4.2. Clinical Research
8.4.3. Others
Chapter 9. Global Plasma Fractionation Market, Regional Analysis
9.1. Top Leading Countries
9.2. Top Emerging Countries
9.3. Plasma Fractionation Market, Regional Market Snapshot
9.4. North America Plasma Fractionation Market
9.4.1. U.S. Plasma Fractionation Market Product breakdown estimates & forecasts, 2020-2030 Method breakdown estimates & forecasts, 2020-2030 Application breakdown estimates & forecasts, 2020-2030 End User breakdown estimates & forecasts, 2020-2030
9.4.2. Canada Plasma Fractionation Market
9.5. Europe Plasma Fractionation Market Snapshot
9.5.1. U.K. Plasma Fractionation Market
9.5.2. Germany Plasma Fractionation Market
9.5.3. France Plasma Fractionation Market
9.5.4. Spain Plasma Fractionation Market
9.5.5. Italy Plasma Fractionation Market
9.5.6. Rest of Europe Plasma Fractionation Market
9.6. Asia-Pacific Plasma Fractionation Market Snapshot
9.6.1. China Plasma Fractionation Market
9.6.2. India Plasma Fractionation Market
9.6.3. Japan Plasma Fractionation Market
9.6.4. Australia Plasma Fractionation Market
9.6.5. South Korea Plasma Fractionation Market
9.6.6. Rest of Asia Pacific Plasma Fractionation Market
9.7. Latin America Plasma Fractionation Market Snapshot
9.7.1. Brazil Plasma Fractionation Market
9.7.2. Mexico Plasma Fractionation Market
9.8. Middle East & Africa Plasma Fractionation Market
9.8.1. Saudi Arabia Plasma Fractionation Market
9.8.2. South Africa Plasma Fractionation Market
9.8.3. Rest of Middle East & Africa Plasma Fractionation Market

Chapter 10. Competitive Intelligence
10.1. Key Company SWOT Analysis
10.1.1. Company 1
10.1.2. Company 2
10.1.3. Company 3
10.2. Top Market Strategies
10.3. Company Profiles
10.3.1. Grifols S.A. Key Information Overview Financial (Subject to Data Availability) Product Summary Recent Developments
10.3.2. CSL Limited
10.3.3. Takeda Pharmaceutical Company Limited
10.3.4. Octapharma AG
10.3.5. Kedrion S.p.A
10.3.6. LFB S.A.
10.3.7. Biotest AG
10.3.8. Sanquin
10.3.9. Bio Products Laboratory Ltd.
10.3.10. Intas Pharmaceuticals Ltd
Chapter 11. Research Process
11.1. Research Process
11.1.1. Data Mining
11.1.2. Analysis
11.1.3. Market Estimation
11.1.4. Validation
11.1.5. Publishing
11.2. Research Attributes
11.3. Research Assumption

At Bizwit Research and Consultancy, we employ a thorough and iterative research methodology with the goal of minimizing discrepancies, ensuring the provision of highly accurate estimates and predictions over the forecast period. Our approach involves a combination of bottom-up and top-down strategies to effectively segment and estimate quantitative aspects of the market, utilizing our proprietary data & AI tools. Our Proprietary Tools allow us for the creation of customized models specific to the research objectives. This enables us to develop tailored statistical models and forecasting algorithms to estimate market trends, future growth, or consumer behavior. The customization enhances the accuracy and relevance of the research findings.
We are dedicated to clearly communicating the purpose and objectives of each research project in the final deliverables. Our process begins by identifying the specific problem or challenge our client wishes to address, and from there, we establish precise research questions that need to be answered. To gain a comprehensive understanding of the subject matter and identify the most relevant trends and best practices, we conduct an extensive review of existing literature, industry reports, case studies, and pertinent academic research.
Critical elements of methodology employed for all our studies include:
Data Collection:
To determine the appropriate methods of data collection based on the research objectives, we consider both primary and secondary sources. Primary data collection involves gathering information directly from various industry experts in core and related fields, original equipment manufacturers (OEMs), vendors, suppliers, technology developers, alliances, and organizations. These sources encompass all segments of the value chain within the specific industry. Through in-depth interviews, we engage with key industry participants, subject-matter experts, C-level executives of major market players, industry consultants, and other relevant experts. This allows us to obtain and validate critical qualitative and quantitative information while evaluating market prospects. AI and Big Data are instrumental in our primary research, providing us with powerful tools to collect, analyze, and derive insights from data efficiently. These technologies contribute to the advancement of research methodologies, enabling us to make data-driven decisions and uncover valuable findings.
In addition to primary sources, we extensively utilize secondary sources to enhance our research. These include directories, databases, journals focusing on related industries, company newsletters, and information portals such as Bloomberg, D&B Hoovers, and Factiva. These secondary sources enable us to identify and gather valuable information for our comprehensive, technical, market-oriented, and commercial study of the market. Additionally, we utilize AI algorithms to automate the collection of vast amounts of data from various sources such as surveys, social media platforms, online transactions, and web scraping. And employ Big Data technologies for storage and processing of large datasets, ensuring that no valuable information is missed during the data collection process.
Data Analysis:
Our team of experts carefully examine the gathered data using suitable statistical techniques and qualitative analysis methods. For quantitative analysis, we employ descriptive statistics, regression analysis, and other advanced statistical methods, depending on the characteristics of the data. This analysis may also incorporate the utilization of AI tools and big data analysis techniques to extract meaningful insights.
To ensure the accuracy and reliability of our findings, we extensively leverage data science techniques, which help us minimize discrepancies and uncertainties in our analysis. We employ Data Science to clean and preprocess the data, ensuring its quality and reliability. This involves handling missing data, removing outliers, standardizing variables, and transforming data into suitable formats for analysis. The application of data science techniques enhances our accuracy, efficiency, and depth of analysis, enabling us to stay competitive in dynamic market environments.
Market Size Estimation:
Our proprietary data tools play a crucial role in deriving our market estimates and forecasts. Each study involves the creation of a unique and customized model. The model incorporates the gathered information on market dynamics, technology landscape, application development, and pricing trends. AI techniques, such as machine learning and deep learning, aid us to analyze patterns within the data to identify correlations, trends, and relationships. By recognizing patterns in consumer behavior, purchasing habits, or market dynamics, our AI algorithms aid us in more precise estimations of market size. These factors are simultaneously analyzed within the model, allowing for a comprehensive assessment. To quantify their impact over the forecast period, correlation, regression, and time series analysis are employed.
To estimate and validate the market size, we employ both top-down and bottom-up approaches. The preference is given to a bottom-up approach, where key regional markets are analyzed as separate entities. This data is then integrated to obtain global estimates. This approach is crucial as it provides a deep understanding of the industry and helps minimize errors.
In our forecasting process, we consider various parameters such as economic tools, technological analysis, industry experience, and domain expertise. By taking all these factors into account, we strive to produce accurate and reliable market forecasts. When forecasting, we take into consideration several parameters, which include:
Market driving trends and favorable economic conditions
Restraints and challenges that are expected to be encountered during the forecast period.
Anticipated opportunities for growth and development
Technological advancements and projected developments in the market
Consumer spending trends and dynamics
Shifts in consumer preferences and behaviors.
The current state of raw materials and trends in supply versus pricing
Regulatory landscape and expected changes or developments.
The existing capacity in the market and any expected additions or expansions up to the end of the forecast period.
To assess the market impact of these parameters, we assign weights to each one and utilize weighted average analysis. This process allows us to quantify their influence on the market and derive an expected growth rate for the forecasted period. By considering these various factors and applying a weighted analysis approach, we strive to provide accurate and reliable market forecasts.
Insight Generation & Report Presentation:
After conducting the research, our experts analyze the findings in relation to the research objectives and the specific needs of the client. They generate valuable insights and recommendations that directly address the client’s business challenges. These insights are carefully connected to the research findings to provide a comprehensive understanding.
Next, we create a well-structured research report that effectively communicates the research findings, insights, and recommendations to the client. To enhance clarity and comprehension, we utilize visual aids such as charts, graphs, and tables. These visual elements are employed to present the data in an engaging and easily understandable format, ensuring that the information is accessible and visually appealing to the client. Our aim is to deliver a clear and concise report that conveys the research findings effectively and provides actionable recommendations to meet the client’s specific needs.

Need Assistance

Contact Person -
Krishant Mennon
Call us @
+ 91 99931 15879
Email: sales@bizwitresearch.com


Why Choose Us?

Quality over Quantity

Backed by 60+ paid data sources our reports deliver crisp insights with no compromise quality.

Analyst Support

24x7 Chat Support plus
free analyst hours with every purchase

Flawless Methodology

Our 360-degree approach of market study, our research methods leave stones unturned.
Enquiry Now